Logo image of MSS

MAISON SOLUTIONS INC-A (MSS) Stock Fundamental Analysis

NASDAQ:MSS - Nasdaq - US5606671072 - Common Stock

1.14  +0.06 (+5.56%)

Fundamental Rating

1

MSS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 41 industry peers in the Consumer Staples Distribution & Retail industry. MSS may be in some trouble as it scores bad on both profitability and health. MSS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

MSS had negative earnings in the past year.
MSS had a positive operating cash flow in the past year.
MSS Yearly Net Income VS EBIT VS OCF VS FCFMSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

The Return On Assets of MSS (-3.48%) is worse than 70.00% of its industry peers.
The Return On Equity of MSS (-26.34%) is worse than 72.50% of its industry peers.
Industry RankSector Rank
ROA -3.48%
ROE -26.34%
ROIC N/A
ROA(3y)-0.86%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MSS Yearly ROA, ROE, ROICMSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

The Gross Margin of MSS (23.92%) is comparable to the rest of the industry.
MSS's Gross Margin has been stable in the last couple of years.
MSS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.25%
GM growth 5YN/A
MSS Yearly Profit, Operating, Gross MarginsMSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 -5 10 15 20

0

2. Health

2.1 Basic Checks

MSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
MSS has more shares outstanding than it did 1 year ago.
The debt/assets ratio for MSS is higher compared to a year ago.
MSS Yearly Shares OutstandingMSS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
MSS Yearly Total Debt VS Total AssetsMSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 1.01, we must say that MSS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MSS (1.01) is worse than 85.00% of its industry peers.
A Debt/Equity ratio of 1.24 is on the high side and indicates that MSS has dependencies on debt financing.
The Debt to Equity ratio of MSS (1.24) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF N/A
Altman-Z 1.01
ROIC/WACCN/A
WACC6.58%
MSS Yearly LT Debt VS Equity VS FCFMSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

MSS has a Current Ratio of 0.48. This is a bad value and indicates that MSS is not financially healthy enough and could expect problems in meeting its short term obligations.
MSS has a Current ratio of 0.48. This is amonst the worse of the industry: MSS underperforms 92.50% of its industry peers.
MSS has a Quick Ratio of 0.48. This is a bad value and indicates that MSS is not financially healthy enough and could expect problems in meeting its short term obligations.
MSS has a Quick ratio of 0.18. This is amonst the worse of the industry: MSS underperforms 85.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.18
MSS Yearly Current Assets VS Current LiabilitesMSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M 25M

2

3. Growth

3.1 Past

The earnings per share for MSS have decreased strongly by -321.04% in the last year.
The Revenue has grown by 9.99% in the past year. This is quite good.
The Revenue has been growing by 12.10% on average over the past years. This is quite good.
EPS 1Y (TTM)-321.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-369.17%
Revenue 1Y (TTM)9.99%
Revenue growth 3Y12.1%
Revenue growth 5YN/A
Sales Q2Q%125.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MSS Yearly Revenue VS EstimatesMSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M 50M
MSS Yearly EPS VS EstimatesMSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

MSS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MSS Price Earnings VS Forward Price EarningsMSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MSS is valued a bit more expensive than the industry average as 72.50% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 57.64
MSS Per share dataMSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MSS!.
Industry RankSector Rank
Dividend Yield N/A

MAISON SOLUTIONS INC-A

NASDAQ:MSS (1/21/2025, 8:15:42 PM)

1.14

+0.06 (+5.56%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.49%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.45M
AnalystsN/A
Price TargetN/A
Short Float %6.41%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF 30.82
P/B 2.05
P/tB N/A
EV/EBITDA 57.64
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.04
OCFY3.24%
SpS4.63
BVpS0.56
TBVpS-0.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.48%
ROE -26.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.92%
FCFM N/A
ROA(3y)-0.86%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.25%
GM growth 5YN/A
F-Score4
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF N/A
Debt/EBITDA 31.87
Cap/Depr 225.79%
Cap/Sales 2.13%
Interest Coverage N/A
Cash Conversion 170.52%
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.18
Altman-Z 1.01
F-Score4
WACC6.58%
ROIC/WACCN/A
Cap/Depr(3y)249.77%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-321.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-369.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.99%
Revenue growth 3Y12.1%
Revenue growth 5YN/A
Sales Q2Q%125.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-481.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1672.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-823.51%
OCF growth 3YN/A
OCF growth 5YN/A